Nelarabine Articles

More NCEs added to Japan's NHI reimbursement list late December

14 January 2008

GSK's Atriance approved by EC

3 September 2007

GSK to launch Atriance in Europe

16 July 2007

GSK's Tykerb under EMEA review

16 October 2006

GSK files Atriance for blood cancers with EC

10 July 2006

JPMA issues guidelines for research tool patent

30 January 2006

GSK to move four cancer drug candidates into late-stage development in 2006

12 December 2005

GlaxoSmithKline's R&D pipeline looks set to drive near-term growth

21 February 2005

Promising new data for GSK's nelarabine

22 December 2003

Showing 1-9 of 9 articles

Go to beginning

Previous

1

Next

Go to end